The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting

Journal of the American College of Cardiology

Volumn 40, Issue 2, 2002, Pages 231-237

  Hongo, Richard H ^a   Ley, Jill ^a   Dick, Stuart E ^a   Yee, Rupsa R ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DRUG EFFECT; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOCRIT; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PLASMA TRANSFUSION; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTHROMBIN TIME; REOPERATION; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME; TUBE;

AGED; ASPIRIN; CORONARY ARTERY BYPASS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; RESEARCH DESIGN; TICLOPIDINE; TREATMENT OUTCOME;

EID: 0037125390     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)01954-X     Document Type: Article

References (62)

1. Angiographlc follow-up after placement of a self-expanding coronary artery stent
2. Combined antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoronary stent management
3. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The Full Anticoagulation Versus Aspirin and Ticlopidine (FANTASTIC) study
4. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients. The Multicenter Aspirin and Ticlopidine Trial after Intracoronary Stenting (MATTIS)
5. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents
6. A clinical trial comparing three antithrombotic-drug regimens after coronary artery stenting. Stent Anticoagulation Restenosis Study Investigators
7. Thrombotic thrombocytopenic purpura associated with ticlopidine: A review of 60 cases
8. Clopidogrel, a novel antiplatelet and antithrombotic agent
9. Clopidogrel loading dose regimens: Kinetic profile of pharmacodynamic response in healthy subjects
10. Comparative safety and tolerability of clopidogrel and aspirin: Results from CAPRIE. Clopidogrel versus aspirin in patients at risk of ischemic events
11. Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population
12. Thienopyridines or aspirin to prevent stoke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials
13. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
14. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: The CLopidogrel ASpirin Stent International Cooperative Study (CLASSICS)
15. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents
16. Factors associated with excessive postoperative blood loss, and hemostatic transfusion requirements: A multivariate analysis in cardiac surgical patients
17. Reexploration for hemorrhage following coronary artery bypass grafting: Incidence and risk factors
18. Results of CURE trial for acute coronary syndrome
19. Combination therapy with clopidogrel and aspirin after coronary stenting
20. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents
21. Clopidogrel versus ticlopidine after intracoronary stent placement
22. Clopidogrel as adjunctive antiplatelet therapy during coronary stenting
23. Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting
24. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation
25. Pharmacodynamics of ticlopidine in man in relation to plasma and blood cell concentration
26. Pharmacodynamics of ticlopidine: Relationship between dose and time of administration to platelet inhibition
27. Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilation procedures
28. Ticlopidine and clopidogrel
29. The antiplatelet effects of ticlopidine and clopidogrel
30. Platelet inhibitors and bleeding in cardiac surgical patients
31. Coronary artery bypass graft in abciximab-treated patients
32. Abciximab and bleeding during coronary surgery: Results from the EPILOG and EPISTENT trials
33. Clinical experience in coronary bypass surgery for abciximab-treated patients
34. Amelioration of the bleeding tendency of preoperative aspirin after aortocoronary bypass grafting
35. Aprotinin counterbalances an increased risk of peri-operative hemorrhage in CABG patients pretreated with aspirin
36. Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations
37. Platelet protection by low-dose aprotinin in cardiopulmonary bypass: Electron microscopic study
38. The platelet in cardiopulmonary bypass
39. Aprotinin reduces clopidogrel-induced prolongation of the bleeding time in the rat
40. Long-term fate of bypass grafts: The Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences
41. A platelet inhibitor-drug trial in coronary artery bypass operations: Benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency
42. Aspirin use and survival after coronary artery bypass surgery
43. Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study
44. Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery
45. Preoperative aspirin therapy and reoperation for bleeding after coronary artery bypass surgery
46. Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements
47. Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting
48. Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting
49. Relation of preoperative use of aspirin to increase mediastinal blood loss after coronary artery bypass graft surgery
50. A prospective study of aspirin's effect on red blood cell loss in cardiac surgery
51. Aspirin does not increase allogenic blood transfusion in reoperative coronary artery bypass surgery
52. Aspirin does not increase homologous blood requirements in elective coronary bypass surgery
53. Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients
54. Effects of profound platelet inhibition with c7E3 before coronary angioplasty on complications of coronary bypass surgery
55. Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins. RGD-containing peptides from viper venoms
56. Tirofiban provides "platelet anesthesia" during cardiopulmonary bypass in baboons
57. Inhibition of platelet adhesion during cardiopulmonary bypass reduces postoperative bleeding
58. Hemostatic function of aspirin-treated platelets vulnerable to cardiopulmonary bypass. Altered shear-induced pathway
59. Effects of clopidogrel on platelet activation and coagulation of non-anticoagulated rat blood under high shear stress
60. Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery
61. Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis
62. Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: Enhanced inhibitory effects of combination therapy